Concord Healthcare Group Co., Ltd. (2453.HK)
HKSE · HKD · Healthcare · Medical Care Facilities
HK$0.61 (+1.67%) as of
Key statistics
- Market cap
- 478.03M
- EPS (TTM)
- -0.230
- Dividend yield
- 0.00%
- 52-week range
- 0.590 – 2.700
- Beta
- -0.47
- Revenue (TTM)
- 528.67M
- Profit margin
- -29.76%
- Volume
- 21.60k
About Concord Healthcare Group Co., Ltd.
Concord Healthcare Group Co., Ltd. provides oncology healthcare service for cancer patients and third-party medical institutions in the People's Republic of China. It operates through Hospital Business; and Medical Equipment, Software and Related Services segments. The company offers oncology-related services, including sale and installation of medical equipment and software; and management and technical support services to hospitals and radiotherapy centers. It also engages in leasing radiotherapy and diagnostic imaging equipment; trading of radiotherapy and diagnostic imaging equipment; technology promotion and application solutions; medical treatment and service, and equipment trading activities; and provision of cancer treatment services. Concord Healthcare Group Co., Ltd. was incorporated in 2008 and is headquartered in Beijing, China.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Headquarters
- Beijing, China
- Employees
- 574
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.